Search bioRxiv⌕ Search

bioRxiv · 10.64898/2026.09.09.750351

The meiotic synaptonemal complex is assembled from independently regulated gene programmes

Abstract

Synaptonemal complex (SC) proteins assemble a highly specialised chromosome structure during meiosis and are considered products of a coordinated germline programme that is silenced in somatic cells. Here, we show that this binary model does not describe the regulation of the eight core mammalian SC genes. Despite assembling into a single molecular complex, SC genes follow distinct regulatory trajectories from meiotic entry through SC disassembly. Their activation is staggered, transcripts and proteins persist with different kinetics after SC disassembly begins in late pachytene, and RNA abundance generally fails to predict protein abundance, revealing extensive regulation between transcription and protein accumulation. Integrating promoter state, nascent transcription, RNA and translational measurements identified gene-specific regulatory strategies rather than a shared SC regulatory mechanism. This independence extends beyond the germline and explains how cancers can express individual SC genes. In cancer cells, individual SC loci occupy distinct transcriptional states, including conventional promoter activation, alternative promoter usage, cell-cycle-dependent transcription and promoter competence without detectable productive transcription. DNA methylation can repress individual SC promoters but does not define a common somatic OFF state, while related transcriptional inputs produce different downstream RNA outputs between SC genes. Unexpectedly, single-cell transcriptomes across healthy mouse and human tissues reveal that somatic SC expression is not restricted to cancer: individual SC genes show reproducible associations with specific cell populations, including fibroblasts, myeloid cells, Schwann cells and progenitors. Thus, SC proteins are neither expressed nor silenced as an obligately coupled gene set. We propose that SC identity emerges from the temporally restricted convergence and assembly of independently regulated genes and proteins during meiosis, while their regulatory autonomy permits individual components to be retained or redeployed in normal somatic cells and cancer. The SC therefore represents an emergent molecular state: its components retain distinct regulatory identities, while their transient convergence during meiotic prophase generates a structure and function that none defines individually.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Brennan, L. C., Fawcett, C. J., Sou, I. F., Bates, A. D., Saifudeen, A., Ikert, M. A., Ginesta, A. G., Hammond, B., McClurg, U. L.. 2026-09-11. The meiotic synaptonemal complex is assembled from independently regulated gene programmes. https://doi.org/10.64898/2026.09.09.750351

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Sequence context and partner availability specify divergent cell fates from a single transcription factor

Transcription factors drive the gene regulatory networks that control developmental transitions, yet which of their many targets a cell uses remains unresolved. Expressing Cebp, Cebp{beta} or Cebp{delta} identically, alone or with Oct4, Sox2, Klf4 and cMyc, gave four outcomes: adipocyte from fibroblasts and neural stem cells, trophectoderm from embryonic stem cells, and myeloid from B cells. Raising Cebp levels changed how many sites it reached, not which sequence it read: clustered motifs maintained somatic enhancers, while spillover onto low-copy sites created de novo enhancers carrying composites of Cebp and cell-type-restricted partners. In fibroblasts, Cebp also redistributed Oct4, Sox2 and Klf4 from early targets, blocking iPSC formation. Supplying the predicted partners rewrote the output: Spi1 redirected Cebp into parallel adipogenic and myeloid programs, via a transient PpargCD45 state using separate enhancers for each; TFAP2C abolished adipogenic conversion. Motif density and partner composites therefore assemble a factor's instructive output in the receiving cell.

cell biology↗

Tracking the conformational dynamics of single molecules in live cells; GTPase cycling in Cdc42 gradients and microclusters

The Rho family of GTPases play a critical role in many cellular processes by acting as molecular switches relying on conformational changes to transition between active and inactive states. The spatial distribution and kinetics of these conformational changes are complex and vary across the cell. We describe here biosensors based on environment-responsive fluorescent dyes, capable of reporting the conformational changes of individual GTPase molecules as they traffic within living cells (SPARC Cdc42 and SPARC Rac1, 'Single Particle Activation Reporter Constructs'). We use SPARC Cdc42 to determine the rates of different steps in GTPase regulation, activation/inactivation and membrane insertion, that together generate localized gradients of Cdc42 activity driving cell motility. The biosensors also revealed heterogeneously distributed clusters of Cdc42, the mechanisms of their activation, and potential roles in polarized motility.

cell biology↗

High-content screening identifies FDA-approved activators of mitophagy

Mitochondrial diseases are highly heterogeneous disorders caused by defects in oxidative phosphorylation, for which only limited therapeutic options are available. The elimination of dysfunctional mitochondria via mitophagy activation is an attractive strategy to treat several mitochondrial diseases, irrespective of the underlying genetic defect. To identify pharmacological activators of this pathway, we performed a high-content screening of 1,971 FDA-approved compounds using cellular reporters of TFEB nuclear translocation and mitophagy. This screening identified 294 compounds that promoted TFEB translocation, nine of which increased the number of mitolysosomes without compromising cell viability or damaging mitochondria. Among the selected compounds, Meptazinol and Ponatinib emerged as the top-ranked mitophagy inducers in fibroblasts from patients with complex I and IV deficiency, respectively, and were prioritised for further characterisation. However, they did not rescue the bioenergetic defect, suggesting that the stimulation of mitophagy per se is not sufficient to ameliorate the OXPHOS defect in mitochondrial diseases. Overall, our findings establish a scalable platform for the identification of pharmacological activators of TFEB and identify candidate compounds for therapeutic modulation of mitophagy.

cell biology↗